D2R News
Stay informed about D2R updates by subscribing to our mailing list!
Ï㽶ÊÓƵ
On this page, you will find press releases, media coverage, newsletters, and annual reports, among others, allowing you to follow D2R’s latest news. For all interview or information requests from media representatives, please contact D2R.comms [at] mcgill.ca .Ìý
Press Releases
-
Philippe Gros appointed Chief Scientific Officer of D2RÌý(October 2024)
-
D2R welcomes Ï㽶ÊÓƵ and genomic researchers to Université de Sherbrooke (October 2024)
-
Génome Québec invests up to $500,000 to boost Ï㽶ÊÓƵ therapeutics innovation in Quebec (October 2024)
-
D2R awards $7.3 million to Advance Research in Genomic-Based Ï㽶ÊÓƵ Therapeutics (September 2024)
-
$165-million for Ï㽶ÊÓƵ’s world-leading inclusive genomics and Ï㽶ÊÓƵ research program (´¡±è°ù¾±±ôÌý2023)
Media coverage
- (LeDevoir, March 2024)
- (Innovation News Network, February 2024)
- (Maclean's, December 2023)
- (University World News, May 2023)
- (CTV News, April 2023)
- Ìý(Government of Canada, April 2023)
D2R Newsletters
Ìý
Reports & Factsheets
- McGill's 2023 Annual Report on Research and Innovation. D2R is mentioned on pages 10-12.
- D2R Factsheet
- D2R Booklet
Ìý
